> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Call Out Lawyer Client-Seeking Ads: Petition
- URL: https://www.fdaweb.com/call-out-lawyer-client-seeking-ads-petition/
- Published: 2023-05-24T12:00:00.000Z
- Updated: 2026-09-14T18:33:50.000Z
- Author: David McFarland
- Tags: Drugs, Devices, #legacy-id-D5154534

University of Florida law professor **Lars Noah** wants FDA to take administrative action to define when client-seeking ads by personal injury lawyers related to FDA-regulated therapeutic products would qualify as potentially misleading lawyer advertising related to drugs and devices. In a 5/19 [petition](https://downloads.regulations.gov/FDA-2023-P-2031-0001/attachment%5F1.pdf?ref=fdaweb.com), Noah attaches an article he wrote for the *University of Illinois Law Review* in 2019 outlining actions he believes the agency should take to discourage aggressive client-seeking campaigns by lawyers that threaten to confuse patients still using FDA-approved therapeutic products.

Noah writes that because state bar associations don’t seem up to the task of taking on client-seeking attorneys, and suits for either negligent misrepresentation or product disparagement would encounter serious obstacles, FDA should take the lead in trying to define what types of attorney drug advertising might cross the line, even though it lacks regulatory jurisdiction over lawyers. “Only then might state officials and courts get the message that some client-seeking ads might well mislead patients in ways that threaten their health,” he concludes.